Is Medline Inc. (MDLN) a Buy, Sell, or Hold?
Medline Inc.
NASDAQ:MDLN
$39.44 USD
$0.78 (2.02%)
- Volume
- 5.88M
- Average Volume
- 9.73M
- Market Capitalization
- $33.35B
- P/E Ratio
- 32.60
- Dividend Yield
- 0.00%
- Price Target
- $55.00
- Year High
- $50.88
- Year Low
- $32.82
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.10
- Current Ratio
- $4.41
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | James Boyle |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Current Symbol | MDLN |
| CUSIP | 58507V107 |
| CIK | 0002046386 |
| Web | https://www.medline.com |
| Phone | (847) 949-5500 |
| Currency | USD |
| Employees | 45000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 1.12 |
| Payout Ratio | 0.10 |
| Current Ratio | 4.41 |
| Quick Ratio | 2.51 |
| Cash Ratio | 0.88 |
Sales & Book Value
| Annual Sales | $28.43B |
| Price / Sales | 1.14 |
| Cash Flow | 1.86 |
| Price / Cash Flow | 21.87 |
| Price / Book | 2.87 |
Price Target and Rating
| Average Stock Price Forecast | $55.00 |
| High Stock Price Forecast | $60.00 |
| Low Stock Price Forecast | $42.00 |
| Forecast Upside/Downside | -28.29% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 14 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $1.43 |
| Trailing P/E Ratio | 32.60 |
| PEG Ratio | 12.82 |
| P/E Growth | 12.82 |
| Net Income | $1.16B |
| Net Margin | 3.31% |
| Pretax Margin | 4.12% |
| Return on Equity | 6.87% |
| Return on Assets | 2.47% |
Financials Score
| AltmanZ Score | 2.18 |
| Piotroski Score | 6.00 |
| Working Capital | 8.64B |
| Total Assets | 39.01B |
| Ebit | 1.8B |
| Market Cap | 33.05B |
| Total Liabilities | 19.66B |
Poll Results
About Medline Inc. (NASDAQ:MDLN) Stock
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable ... medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
2026-07-09 17:32:00
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
2026-07-07 20:54:00
SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols—specifically failures to investigate microbial incidents and batch discrepancies—that prompted regulatory scrutiny and triggered a significant decline in the company's share price.
2026-07-07 17:57:00
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
2026-07-06 11:00:00
Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
2026-07-06 10:49:00
Massive new medical supplies distribution space represents 45% expansion of Medline's customer-facing NorCal footprint NORTHFIELD, Ill., July 6, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announced a lease agreement for an existing 925,000-square-foot warehouse in Tracy, Calif.
Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'
2026-07-02 07:39:16
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Medline Inc. (NASDAQ:MDLN), adding that it is “probably the best IPO of the year.”
2026-07-01 15:45:00
SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols—specifically failures to investigate microbial incidents and batch discrepancies—that prompted regulatory scrutiny and triggered a significant decline in the company's share price.
Medline to report second quarter 2026 results on August 5, 2026
2026-07-01 09:00:00
NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report second quarter 2026 financial results on Wednesday, August 5, 2026.
Frequently Asked Questions
-
What is the current Medline Inc. (MDLN) stock price?
-
Medline Inc.(NASDAQ:MDLN) stock price is $39.44 in the last trading session. During the trading session, MDLN stock reached the peak price of $50.876 while $32.815 was the lowest point it dropped to. The percentage change in MDLN stock occurred in the recent session was 2.02% while the dollar amount for the price change in MDLN stock was $0.78.
-
MDLN's industry and sector of operation?
-
The NASDAQ listed MDLN is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of MDLN?
-
Ben Fox | Vice President of Corporate Communications
Alex Liberman | Chief Legal Officer
James Boyle | CEO & Director
Douglas Golwas | Chief Commercial Officer
Michael Drazin | Chief Financial Officer -
How many employees does MDLN have?
-
Number of MDLN employees currently stands at 45000. MDLN operates from 3 Lakes Drive, Northfield, IL 60093, US.
-
Link for MDLN official website?
-
Official Website of MDLN is: https://www.medline.com
-
How do I contact MDLN?
-
MDLN could be contacted at phone #(847) 949-5500 and can also be accessed through its website. MDLN operates from 3 Lakes Drive, Northfield, IL 60093, US.
-
How many shares of MDLN are traded daily?
-
The average number of MDLN shares traded daily for last 3 months was 9.73M.
-
What is the market cap of MDLN currently?
-
The market value of MDLN currently stands at $33.35B with its latest stock price at $39.44